| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adalimumab in rheumatoid arthritis
|
Moreland, Larry
|
|
2004
|
6 |
5 |
p. 333-334
|
artikel
|
| 2 |
Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: Possible interactions and implications for treatment of rheumatoid arthritis
|
Kurth, Tobias
|
|
2004
|
6 |
5 |
p. 351-356
|
artikel
|
| 3 |
B cells: New ways to inhibit their function in rheumatoid arthritis
|
Carter, Robert H.
|
|
2004
|
6 |
5 |
p. 357-363
|
artikel
|
| 4 |
Biomarkers in systemic lupus erythematosus
|
Illei, Gabor G.
|
|
2004
|
6 |
5 |
p. 382-390
|
artikel
|
| 5 |
Current advances in the human lupus genetics
|
Shen, Nan
|
|
2004
|
6 |
5 |
p. 391-398
|
artikel
|
| 6 |
Etanercept and methotrexate combination in rheumatoid arthritis
|
Moreland, Larry
|
|
2004
|
6 |
5 |
p. 333
|
artikel
|
| 7 |
Gene targeting: Roadmap to future therapies
|
Huber, Lars C.
|
|
2004
|
6 |
5 |
p. 323-325
|
artikel
|
| 8 |
Infliximab in rheumatoid arthritis
|
Moreland, Larry
|
|
2004
|
6 |
5 |
p. 334-335
|
artikel
|
| 9 |
Literature alert
|
|
|
2004
|
6 |
5 |
p. 328-329
|
artikel
|
| 10 |
New advances in measurement of complement activation: Lessons of systemic lupus erythematosus
|
Liu, Chau-Ching
|
|
2004
|
6 |
5 |
p. 375-381
|
artikel
|
| 11 |
Occupational and environmental exposures as risk factors for systemic lupus erythematosus
|
Cooper, Glinda S.
|
|
|
6 |
5 |
p. 367-374
|
artikel
|
| 12 |
Occupational and environmental exposures as risk factors for systemic lupus erythematosus
|
Cooper, Glinda S.
|
|
2004
|
6 |
5 |
p. 367-374
|
artikel
|
| 13 |
Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis
|
McInnes, Iain B.
|
|
2004
|
6 |
5 |
p. 336-342
|
artikel
|
| 14 |
Update on autoantibodies in rheumatoid arthritis
|
Bridges, S. Louis
|
|
2004
|
6 |
5 |
p. 343-350
|
artikel
|
| 15 |
Web alert
|
|
|
2004
|
6 |
5 |
p. 326-327
|
artikel
|
Tijdschrift beschrijving